AdvisorNet Financial Inc Grows Position in CVS Health Corporation $CVS

AdvisorNet Financial Inc lifted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 541.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,478 shares of the pharmacy operator’s stock after purchasing an additional 18,130 shares during the quarter. AdvisorNet Financial Inc’s holdings in CVS Health were worth $1,619,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of CVS. Wellington Management Group LLP increased its stake in CVS Health by 83.2% in the first quarter. Wellington Management Group LLP now owns 403,365 shares of the pharmacy operator’s stock valued at $27,328,000 after acquiring an additional 183,232 shares during the last quarter. Dorsey & Whitney Trust CO LLC boosted its holdings in shares of CVS Health by 10.7% in the 1st quarter. Dorsey & Whitney Trust CO LLC now owns 7,378 shares of the pharmacy operator’s stock worth $500,000 after purchasing an additional 715 shares in the last quarter. Compound Planning Inc. increased its position in shares of CVS Health by 53.0% during the 1st quarter. Compound Planning Inc. now owns 22,223 shares of the pharmacy operator’s stock valued at $1,506,000 after purchasing an additional 7,694 shares during the last quarter. Kestra Advisory Services LLC raised its holdings in shares of CVS Health by 8.3% during the 1st quarter. Kestra Advisory Services LLC now owns 86,770 shares of the pharmacy operator’s stock valued at $5,879,000 after buying an additional 6,642 shares in the last quarter. Finally, Allstate Corp lifted its position in CVS Health by 14.6% in the 1st quarter. Allstate Corp now owns 42,886 shares of the pharmacy operator’s stock worth $2,906,000 after buying an additional 5,454 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Price Performance

Shares of CVS stock opened at $77.70 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $85.15. The firm has a market cap of $98.63 billion, a P/E ratio of 204.47, a P/E/G ratio of 0.77 and a beta of 0.48. The business’s 50 day moving average price is $79.09 and its 200-day moving average price is $72.43.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Evercore ISI lifted their price target on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Jefferies Financial Group lifted their target price on shares of CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Zacks Research cut CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Piper Sandler reissued an “overweight” rating and issued a $101.00 target price (up previously from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 15th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $94.67.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.